Artemisia Annua based Drug might be used to counter covid-19

Covid-19 Treatment with Artemisia annua, Artemisia Annua,
An Artemisia Plant growing in a filed.
Image Courteous: France 24


KeyNote

According to Madagascar's President, artemisia annua, an african herbal, based drug is a good advancement towards the fightting with covid-19 disease.



Andry Rajoelina, President of Madagascar, had praising the benefits of Artemisia annua, a herbal, in his long address on television last weekend,  and declare it as highly effective treatment against covid-19 pandemic.  It is also increasing its grip in other African countries. Although, World Health Organization raised the question it must be tested for its efficacy and adverse side effect before approval.


Referring to his one-and-half hour long speech, an Artemisia plant, a bottle of syrup made up of Artemisia herbal, and packages of covid-organics, the branded Artemisia products are all placed near to him to promote it as treatment of coronavirus disease.


Artemisia based injections will go under clinical trial from the next week, said Rajoelina, urging  that any kind of criticism on herbal-based treatment must be stop, according to representative of RFI’s in Antananarivo.

The President urged people to continue following measures on regular basis to put a break on covid-19 pandemic pace. The major portion of the address had covered the plant “Artemisia. In addition, He made two announcements: production of plant, Artemisia, on large scale, and setting up a factory to make medicine form upcoming month.


This plant has capacity to deal with plenty of diseases. If we don’t rush fast, the competitors will overpass us, Said Rajoelina, as reported by Laetitia Bezain, a correspondent of RFI.


Africa’s Covid-19 Treatment


The ruling parties of other African countries have showed their interest in Artemisia to defeat covid-19 disease. 


John Magufuli, President of Tanzania, said he approached the Madagascar government and sent an airplane to pick up medicine made up of Artemisia.

Denis Sassou Nguesso, President of Congo Brazzaville, has confirmed that they would import artemisa too and follow the measure of covid-organic treatment after having video conference with Rajoelina, as tweeted bygovernment spokesperson Thierry Moungalla.


Senegal on 24th April placed its first order, revealed byMadagascar’s leader through his social media post

Drilling Down Artemisia


The Madagascar’s government is not only single player to drill down the benefits of the plant Artemisia as an effective and quick remedy against covid-19 disease but some other players are too participating to test the efficacy of this vaccine or medicine-For instance Germany’s Max PlanckInstitute of Colloids and Interfaces and US based company ArtemiLife Inc both are working in collaboration on plant extract and its derivatives to determine its efficacy and adverse side effect against novel coronavirus Sars-CoV-2.


The studies carried out in Denmark and Germany have considered the same plant as cultivated and processed in Madagascar’s Land-artemisia annua. The supplies used in the test are provided by ArtemLife Inc, situated in Delaware, claims that it has fields cultivating artemisia outside Lexington, Kentucky.

ArtemiLife is promoting two products containing artemisia annua-tea and coffee. The company suggests that the consumers use these products couple of times in a day-maximizing benefit and keep shield active.


The prices of two products ArtemCafe and ArtemiTea are 91 euros and 73 euros respectively, which are usable for a month that is 30-days. The company encourages all customers to register their interest on its website because the products are still in development phase, and yet not available to sale.


The company adds, these products have no capacity to diagnose, cure, treat or prevent from any disease. ArtemLife further highlights that their claims about Artemisia annua are not backed by the US Food and Drug Administration.

Centuries-old malaria Treatment


This Artemisia plant has been used successfully as treatment for Malaria infection since century. In 340 BC, it was discovered that this plant had antimalarial features as part of traditional Chinese medicine, says Zhou Yiging, an expert at Institute of Microbiology and Epidemiology-a sub unit of Chinese Academy of Military Medical Sciences. 


Zhou’s Research conducted in 1970 led to the plant’s efficacy against the mosquito-borne ailment.


Artemisia was picked up for further scrambling from the list of other herbs and conventional medicines used to treat malaria as investigated by experts.


The project 523 was the first step towards the clinical testing of Artemisia herb by Chinese government to finds out its antimalarial features.


Later, scientists cracked the molecular structure of the Artemisia and explore more derivatives, and finally succeeded in developing first Artemisinin-based Combination Therapy (ACT) for malaria, known as Coartem.


To get different actions using ACT therapy, artemisinin was combined with another active component for the same treatment. 


According to World Health Organization, ACT is the most effective antimalarial drug available today to fight against the mosquito-borne disease-malaria.

The Role of Artemisia in preventing HIV and SARS


The researchers have not restricted their studies of Artemisia only for combatting malaria, but open other directions as well to find out solution to stop covid-19 virus.


A paper, prepared at Leiden University and Basel University, published in the Journal of Ethno-pharmacology investigate Artemisia tea infusion and their activity in fightingagainst HIV.


In July 2005, an article was published by Chinese researchers based on the uses of herbal extract as an antiviral drug in Treatment ofSevere Acute Respiratory Syndrome (SARS), a respiratory sick caused by coronavirus.


The research including Artemisia among other four selected herbals extract conducted by experts at different institutions and companies in Beijing published in the Antiviral Research journal, that could be focused as an candidate for producing a drug that deals with SARS.

Threat for the Pharmaceutical Industry       




Fears over Drug Resistance Doubts over Drug Resistance

WHO in its guidance on malaria treatment informs against using artemisinin as an oral monotherapy. This guideline plays significant role in the development of drug resistance to artemisinin as a treatment.


The use of Artemisia plant is prohibited within France. The HealthMinister of France says that no evidence of controlled clinical trials that proves its efficacy and effectiveness. The National Agency for the Safety of Medicines and Health Products (ANSM) has acted to ban products produced from Artemisia.


In contrast to it, French non-government organizations like La Maison de I’Artemisia promoting the herbal use as malaria treatment, claiming “the plant can save millions of lives”. The NGO pays attention on Sub-Saharan African countries, promoting the use of Artemisia as tea infusion, although notifies people from outside malaria endemic against taking it.


Malaria and covid-19 not the same


The treatment of mosquito-borne ill-malaria with the use of plant Artemisia is clearly beneficial but some questions are still answerable about the exact nature of treatment. Its successful use in fighting against malaria doesn’t provide the same guarantee in case of dealing covid-19.


The African Union Block it was in touch with the Madagascar’s government with idea to have access all technical data regarding the use of Artemisia in terms of safety and efficiency for treating coronavirus pandemic, according to a statement.


It was decided that member state would supply all necessarily data with detail to African union regarding the herbal remedy, the AU said on Tuesday.

The AU added, The Africa Centres for Disease Control and Prevention would further review and analyze collected the scientific data to determine its safety and efficacy.


Frank van der Kooy, the mentor of research on Artemisia and treatment of HIV at Leiden University and the University of Basel, shared with RFI that the lack of fund has made it difficult for us to continue work on it, while research on its use as medicine deal with coronavirus-SARS-CoV-2 must be interpreted cautiously.

At the moment we are not sure that Artemisia will be effective in dealing with Covid-19 but it needs to pass through clinical trials, which demands funds in turn, said van der kooy, who currently works at North-West University in South Africa.


The WHO has not ignored aspect of possible use of Artemisia for treatment of Covid-19, but it should be faces the clinical trial to identify its efficacy and adverse side effects.


Many plants and substances have been selected without minimum requirements and evidence of quality, safety and efficacy. In absence of robust investigation, the use of products based on Artemisia to treat covid-19 can put the lives in danger, ultimately sending signals security weakness and distract them from the measures like washing hands and physical distancing which are prime in covid-19 prevention, said WHO.
Post a Comment (0)
Previous Post Next Post